AHRQ
-
The role of diet in esophageal cancer
New findings suggest that dietary calcium and magnesium affect the risk of esophageal cancer; if confirmed in interventional studies, they could inform dietary modifications to reduce the burden of this cancer. Read MoreMay 4, 2020
-
Phillippi’s study of team-based maternity care bolstered by grant
Julia Phillippi, PhD, CNM, has received a K08 Career Development Award from the Agency for Healthcare Research and Quality (AHRQ) of the U.S. Department of Health and Human Services. Phillippi, a Vanderbilt University School of Nursing assistant professor and certified nurse-midwife, will use the three-year, $399,374 mentored award to conduct a randomized trial of an interdisciplinary team-based maternity care model and examine the preferences of patients and providers. Read MoreJan 4, 2018
-
The toll of dysphagia
Impaired swallowing — dysphagia — affects 3 percent of hospital inpatients, who have longer hospital stays and are more likely to require post-acute care services. Read MoreDec 15, 2017
-
Studies find tonsillectomies offer only modest benefits
Removing tonsils modestly reduced throat infections in the short term in children with moderate obstructive sleep-disordered breathing or recurrent throat infections, according to a systematic review conducted by the Vanderbilt Evidence-based Practice Center for the Agency for Healthcare Research and Quality (AHRQ). Read MoreJan 26, 2017
-
Dittus named to AHRQ’s National Advisory Council
Robert Dittus, M.D., MPH, Executive Vice President, Public Health and Health Care for Vanderbilt University Medical Center (VUMC), has been named to the National Advisory Council of the Agency for Healthcare Research and Quality (AHRQ). Read MoreOct 6, 2016
-
Interventions benefit disruptive behavior in children: review
Children with disruptive behavior disorders (DBDs), such as conduct disorder, are most likely to benefit from psychosocial interventions that include a parental component alone or in combination with other interventions, according to a newly published systematic review by Vanderbilt researchers. Read MoreOct 29, 2015
-
Grant spurs lung cancer surgery research
Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients. Read MoreSep 18, 2014
-
Behavior-focused therapies help children with autism: study
Vanderbilt researchers this week reported updated findings regarding the benefits of behavior-focused therapies for children with autism spectrum disorder (ASD). Read MoreJul 26, 2014
-
VU study shows common diabetes drug can slow chronic kidney disease progression
Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. Read MoreJun 26, 2014
-
Grant bolsters patient-centered outcomes research
Patient-centered outcomes research is the focus of a $3.3 million, five-year, institutional K12 training grant awarded to Vanderbilt University Medical Center by the Agency for Healthcare Research and Quality (AHRQ). Read MoreMar 27, 2014
-
Little evidence supports medical treatment options for adolescents with autism
Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population. Read MoreSep 24, 2012
-
Study tracks hormone’s role in reducing preterm birth risk
Pregnant women who have had prior preterm births may avoid a subsequent early birth if given progestogens, which are natural or synthetic forms of progesterone, a female hormone that naturally increases during pregnancy, a Vanderbilt analysis shows. Read MoreSep 6, 2012
-
Autoimmune drugs don’t boost infection risk: study
A Vanderbilt study shows that a class of drugs used to treat autoimmune diseases does not increase the chance of hospitalization for serious infection. Read MoreNov 18, 2011
-
Vanderbilt study finds no heart risk in ADHD medications
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. Read MoreNov 2, 2011
-
Sex hormone may predict death
Changes in blood levels of the sex hormone estradiol may provide a clinically useful predictor of death in critically ill or injured patients. Read MoreJun 3, 2011